Articles
Is Congress Misleading or Ignorant? Their War on Drug Prices Provides No Answers
The recent Congressional hearing on drug prices, patents, and the pharmaceutical industry has ignited a fervent debate. Unfortunately, much of the discourse has been overshadowed by misunderstandings and misinformation. A nuanced comprehension of the patent system and its pivotal role in drug innovation is essential for fostering informed discussions and Read more…
